-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 4, it was reported that Sinopharm Investment and Huawei "hand in hand", and the two sides are carrying out in-depth strategic cooperation in building new pharmaceutical retail, intelligent manufacturing and digital transformation to help realize the healthy China strategy and better meet the needs of grassroots people for medical and health services
.
On November 3, China Resources Sanjiu made a new foreign investment.
The investment company was Hubei Jiurun Pharmaceutical Technology Co.
, Ltd.
, which is 100% owned by Jointown, and the investment ratio was 51%
.
It is understood that this strategic cooperation has already started as early as October 22.
Jointown announced the same day that it signed a strategic cooperation agreement with China Resources Sanjiu to establish a joint venture, namely "Hubei Jiurun Pharmaceutical Technology Co.
, Ltd.
"
.
Jointown announced that this cooperation is to jointly develop the big health market
.
In addition, not long ago, Alibaba Health announced its cooperation with Ogalon to jointly explore new pharmaceutical retail and disease management models including women’s health, chronic diseases and other fields, and promote China’s medical and health industry through “Internet+” technological innovation.
Realize high-quality digital and intellectual development
.
It can be said that in the field of new pharmaceutical retail, strong alliances have become a trend
.
From the general background, with the rapid development of science and technology, traditional industries such as pharmaceuticals and medical treatment have also undergone a series of reforms.
The drug purchase model has gradually entered people's lives, and the rapid development of Internet pharmacies has brought an impact to offline pharmacies
.
According to statistics, in 2019, only 2.
4% of domestic medicines were distributed through off-hospital online retail pharmacies, and online patient consultations accounted for 6.
0% of the total consultation volume
.
This year, the scale of China's digital big health market was 218 billion yuan, and the digital proportion of the big health market accounted for 3.
3% of China's total medical and health expenditure.
It can be seen that China's medical and health industry is still in the initial stage of digitalization
.
The industry believes that as the concentration of the pharmaceutical retail industry increases, new retail business is developing rapidly, and it is expected that online and offline integrated development will become a trend in the future
.
Especially since 2020, due to the impact of the epidemic and the development opportunities faced by new pharmaceutical retail, many pharmaceutical companies, including Amendment Pharmaceuticals, are actively embracing digitalization for deployment.
.
With the changes and in-depth advancement of the pharmaceutical industry, the big health market has become more open, and the pace of entering the new pharmaceutical retail era is getting faster and faster.
The cooperation between strong companies has also been strengthened.
The system and The layout is more complete
.
In addition to the aforementioned Sinopharm, Alibaba Health and other companies, for example, Taiji Group is working with companies in the field of smart medicine cabinets to respond to the national medical reform, comprehensively deploy new pharmaceutical retail, and jointly operate to create an unmanned smart pharmacy.
This smart pharmacy is not only realizing In addition to self-service drug purchase, it also innovatively implemented various functions such as remote consultation, online ordering and delivery, and online ordering and machine retrieval, allowing pharmacies to operate 7X24 hours, allowing users to find a doctor in 1 minute, and successfully solved the problem.
At present, the common point of the general public is that it is difficult to buy medicines.
In October 2020, Dingdang Kuaiyao and GSK will cooperate.
The “medicine” service ecology will further improve the accessibility of medical treatment for more patients, and realize the integrated online medical and health services of “diagnosis and treatment-purchase medicine” for more patients
.
.
On November 3, China Resources Sanjiu made a new foreign investment.
The investment company was Hubei Jiurun Pharmaceutical Technology Co.
, Ltd.
, which is 100% owned by Jointown, and the investment ratio was 51%
.
It is understood that this strategic cooperation has already started as early as October 22.
Jointown announced the same day that it signed a strategic cooperation agreement with China Resources Sanjiu to establish a joint venture, namely "Hubei Jiurun Pharmaceutical Technology Co.
, Ltd.
"
.
Jointown announced that this cooperation is to jointly develop the big health market
.
In addition, not long ago, Alibaba Health announced its cooperation with Ogalon to jointly explore new pharmaceutical retail and disease management models including women’s health, chronic diseases and other fields, and promote China’s medical and health industry through “Internet+” technological innovation.
Realize high-quality digital and intellectual development
.
It can be said that in the field of new pharmaceutical retail, strong alliances have become a trend
.
From the general background, with the rapid development of science and technology, traditional industries such as pharmaceuticals and medical treatment have also undergone a series of reforms.
The drug purchase model has gradually entered people's lives, and the rapid development of Internet pharmacies has brought an impact to offline pharmacies
.
According to statistics, in 2019, only 2.
4% of domestic medicines were distributed through off-hospital online retail pharmacies, and online patient consultations accounted for 6.
0% of the total consultation volume
.
This year, the scale of China's digital big health market was 218 billion yuan, and the digital proportion of the big health market accounted for 3.
3% of China's total medical and health expenditure.
It can be seen that China's medical and health industry is still in the initial stage of digitalization
.
The industry believes that as the concentration of the pharmaceutical retail industry increases, new retail business is developing rapidly, and it is expected that online and offline integrated development will become a trend in the future
.
Especially since 2020, due to the impact of the epidemic and the development opportunities faced by new pharmaceutical retail, many pharmaceutical companies, including Amendment Pharmaceuticals, are actively embracing digitalization for deployment.
.
With the changes and in-depth advancement of the pharmaceutical industry, the big health market has become more open, and the pace of entering the new pharmaceutical retail era is getting faster and faster.
The cooperation between strong companies has also been strengthened.
The system and The layout is more complete
.
In addition to the aforementioned Sinopharm, Alibaba Health and other companies, for example, Taiji Group is working with companies in the field of smart medicine cabinets to respond to the national medical reform, comprehensively deploy new pharmaceutical retail, and jointly operate to create an unmanned smart pharmacy.
This smart pharmacy is not only realizing In addition to self-service drug purchase, it also innovatively implemented various functions such as remote consultation, online ordering and delivery, and online ordering and machine retrieval, allowing pharmacies to operate 7X24 hours, allowing users to find a doctor in 1 minute, and successfully solved the problem.
At present, the common point of the general public is that it is difficult to buy medicines.
In October 2020, Dingdang Kuaiyao and GSK will cooperate.
The “medicine” service ecology will further improve the accessibility of medical treatment for more patients, and realize the integrated online medical and health services of “diagnosis and treatment-purchase medicine” for more patients
.
